Davide Quaresmini

1.1k total citations · 1 hit paper
20 papers, 699 citations indexed

About

Davide Quaresmini is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Davide Quaresmini has authored 20 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Davide Quaresmini's work include Neuroendocrine Tumor Research Advances (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Davide Quaresmini is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Davide Quaresmini collaborates with scholars based in Italy and United States. Davide Quaresmini's co-authors include Franco Silvestris, Raffaele Palmirotta, Eleonora Pellè, Domenica Lovero, Marco Tucci, Claudia Felici, Paola Cafforio, Francesco Mannavola, Mauro Cives and Francesca Rizzo and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Davide Quaresmini

19 papers receiving 690 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

2018 333 citations Raffaele Palmirotta, Domenica Lovero et al. Therapeutic Advances in Medical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Quaresmini Italy	11	352	265	257	160	119	20	699
Haizhen Lu China	13	231 0.7×	264 1.0×	128 0.5×	99 0.6×	145 1.2×	47	687
Bernies van der Hiel Netherlands	18	386 1.1×	169 0.6×	101 0.4×	72 0.5×	149 1.3×	55	922
Eleonora Pellè United States	12	432 1.2×	224 0.8×	238 0.9×	326 2.0×	80 0.7×	30	723
Ashton A. Connor United States	14	520 1.5×	250 0.9×	219 0.9×	61 0.4×	94 0.8×	50	859
Malaka Ameratunga Australia	14	375 1.1×	268 1.0×	133 0.5×	47 0.3×	282 2.4×	45	824
Heli Gao China	18	531 1.5×	186 0.7×	120 0.5×	238 1.5×	96 0.8×	55	825
Xuxia Shen China	21	365 1.0×	319 1.2×	218 0.8×	128 0.8×	583 4.9×	51	1.1k
Anuradha Chakravarthy United States	13	310 0.9×	128 0.5×	153 0.6×	107 0.7×	170 1.4×	25	950
Alejandro Avilés‐Salas Mexico	14	369 1.0×	295 1.1×	186 0.7×	65 0.4×	249 2.1×	62	768
Marco Bartolotti Italy	18	446 1.3×	214 0.8×	143 0.6×	119 0.7×	554 4.7×	33	897

Countries citing papers authored by Davide Quaresmini

Since Specialization

Citations

This map shows the geographic impact of Davide Quaresmini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Quaresmini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Quaresmini more than expected).

Fields of papers citing papers by Davide Quaresmini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Quaresmini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Quaresmini. The network helps show where Davide Quaresmini may publish in the future.

Co-authorship network of co-authors of Davide Quaresmini

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Quaresmini. A scholar is included among the top collaborators of Davide Quaresmini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Quaresmini. Davide Quaresmini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vitale, Elsa, Davide Quaresmini, Simona De Summa, et al.. (2024). The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials. Frontiers in Oncology. 14. 1409132–1409132.

Brunetti, Oronzo, Giovanni Brandi, Guido Fadda, et al.. (2022). Rare histotypes of epithelial biliary tract tumors: A literature review. Critical Reviews in Oncology/Hematology. 181. 103892–103892. 10 indexed citations

Guida, Michele, Nicola Bartolomeo, Davide Quaresmini, et al.. (2022). Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. Journal of Translational Medicine. 20(1). 159–159. 19 indexed citations

Massafra, Raffaella, Samantha Bove, Daniele La Forgia, et al.. (2022). An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients’ Age: A Retrospective Cohort Study. Cancers. 14(9). 2215–2215. 6 indexed citations

Guida, Michele, Nicola Bartolomeo, Pietro Quaglino, et al.. (2021). No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. Cancers. 13(3). 475–475. 19 indexed citations

Buquicchio, R., et al.. (2021). Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma. Frontiers in Oncology. 11. 691980–691980. 6 indexed citations

Quaresmini, Davide, Livia Fucci, Sabino Strippoli, et al.. (2021). Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp. Frontiers in Oncology. 11. 742666–742666. 6 indexed citations

Strippoli, Sabino, Annarita Fanizzi, Antonio Negri, et al.. (2021). Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma. Cells. 10(2). 406–406. 9 indexed citations

Quaresmini, Davide & Michele Guida. (2020). Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment. Frontiers in Immunology. 11. 584903–584903. 19 indexed citations

10.

Cives, Mauro, Eleonora Pellè, Davide Quaresmini, et al.. (2019). The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. Current Treatment Options in Oncology. 20(9). 72–72. 9 indexed citations

11.

Cives, Mauro, Eleonora Pellè, Davide Quaresmini, et al.. (2019). The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications. Neuroendocrinology. 109(2). 83–99. 90 indexed citations

12.

Cives, Mauro, Stefano Partelli, Raffaele Palmirotta, et al.. (2019). DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors. Scientific Reports. 9(1). 18614–18614. 32 indexed citations

13.

Palmirotta, Raffaele, Domenica Lovero, Luigia Stefania Stucci, et al.. (2018). Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family. International Journal of Molecular Sciences. 19(1). 285–285. 19 indexed citations

14.

Palmirotta, Raffaele, Domenica Lovero, Paola Cafforio, et al.. (2018). Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Therapeutic Advances in Medical Oncology. 10. 3861409670–3861409670. 333 indexed citations breakdown →

15.

Pellè, Eleonora, Mauro Cives, Davide Quaresmini, et al.. (2017). CXCR4 inhibition by ulocuplumab prevents EMT of pNET cells in vitro. Annals of Oncology. 28. v154–v155. 2 indexed citations

16.

Palmirotta, Raffaele, Domenica Lovero, Erica Silvestris, et al.. (2017). Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA). Cancer Genomics & Proteomics. 14(3). 173–179. 36 indexed citations

17.

Marchis, Maria Laura De, Flavio Tonelli, Davide Quaresmini, et al.. (2017). Desmoid Tumors in Familial Adenomatous Polyposis. Anticancer Research. 37(7). 3357–3366. 50 indexed citations

18.

Palmirotta, Raffaele, Domenica Lovero, Erica Silvestris, et al.. (2017). Characterization of a Rare Nonpathogenic Sequence Variant (c.1905C>T) of the Dihydropyrimidine Dehydrogenase Gene (DPYD). The International Journal of Biological Markers. 32(3). 357–360. 3 indexed citations

19.

Palmirotta, Raffaele, Davide Quaresmini, Domenica Lovero, & Franco Silvestris. (2017). ALK Gene Alterations in Cancer: Biological Aspects and Therapeutic Implications. Pharmacogenomics. 18(3). 277–292. 7 indexed citations

20.

Cives, Mauro, Davide Quaresmini, Francesca Rizzo, et al.. (2017). Osteotropism of neuroendocrine tumors: role of the CXCL12/CXCR4 pathway in promoting EMT in vitro. Oncotarget. 8(14). 22534–22549. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact